-+ 0.00%
-+ 0.00%
-+ 0.00%

Neurogene Q4 EPS $(1.13), Inline

Benzinga·03/24/2026 11:39:26
Listen to the news
Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.13) per share which met the analyst consensus estimate. This is a 13 percent decrease over losses of $(1.00) per share from the same period last year.